Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
PlumeSTARS Logo
PlumeSTARS Growth Score
67
CB Rank
222131
Heat Score
58
PlumeSTARS is an innovative PMI specialized in drug delivery to lung for the treatment of respiratory diseases.
Founded
obfuscation
PrivateGrant Parma, Emilia-Romagna, Italy1-10 plumestars.com/
Biotechnology
Medical Device
Overview

PlumeSTARS
Total Funding
obfuscation
Growth Score
67
Heat Score
58

Total Funding
obfuscation
obfuscation
Grant raised
obfuscation
Growth Score67
-5 pts
in past quarter
Heat Score 58
-10 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About PlumeSTARS

CB Rank
222131
PlumeSTARS is an innovative PMI specialized in drug delivery to lung for the treatment of respiratory diseases.
Founded
obfuscation
PrivateGrant Parma, Emilia-Romagna, Italy1-10 plumestars.com/
Biotechnology
Medical Device

Funding Rounds

Grant
OBF
in
obfuscation

Key People

Details

Operating Status Active
Company Type For Profit
Founders  Paolo Colombo
About the Company
PlumeSTARS is an innovative PMI specialized in drug delivery to lung for the treatment of respiratory diseases.
Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

Amikacin Powder for Inhalation (AMIKA PS)
A dry powder formulation of amikacin for inhalation to manage chronic lung infections caused by Pseudomonas aeruginosa in cystic fibrosis patients aged six and above.
Tobramycin Dry Powder Inhaler (TOBRA PS)
A dry powder inhalation formulation of tobramycin developed as an alternative treatment for lung infections in cystic fibrosis patients, designed to improve therapy compliance.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Grant - PlumeSTARS Logo
Grant - PlumeSTARS
1
obfuscation
— Grant
obfuscation
Grant - PlumeSTARS Logo
Grant - PlumeSTARS
1
obfuscation
— Grant
obfuscation
Grant - PlumeSTARS Logo
Grant - PlumeSTARS
1
obfuscation
— Grant
obfuscation
Grant - PlumeSTARS Logo
Grant - PlumeSTARS
1
obfuscation
— Grant
obfuscation
Grant - PlumeSTARS Logo
Grant - PlumeSTARS
1
obfuscation
— Grant

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Grant - PlumeSTARS Logo
Grant - PlumeSTARS
1
obfuscation
— Grant
obfuscation
Grant - PlumeSTARS Logo
Grant - PlumeSTARS
1
obfuscation
— Grant
obfuscation
Grant - PlumeSTARS Logo
Grant - PlumeSTARS
1
obfuscation
— Grant
obfuscation
Grant - PlumeSTARS Logo
Grant - PlumeSTARS
1
obfuscation
— Grant
obfuscation
Grant - PlumeSTARS Logo
Grant - PlumeSTARS
1
obfuscation
— Grant

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.
Investor Name  
Lead Investor  
Funding Round  
Partners  
EISMEA Logo
EISMEA
—
Grant - PlumeSTARS Logo
Grant - PlumeSTARS
—
EISMEA Logo
EISMEA
—
Grant - PlumeSTARS Logo
Grant - PlumeSTARS
—
EISMEA Logo
EISMEA
—
Grant - PlumeSTARS Logo
Grant - PlumeSTARS
—
EISMEA Logo
EISMEA
—
Grant - PlumeSTARS Logo
Grant - PlumeSTARS
—
EISMEA Logo
EISMEA
—
Grant - PlumeSTARS Logo
Grant - PlumeSTARS
—
Market Intelligence
People
View Profiles & Contacts
Headcount 1-10 Employee Profiles 1

Employee Profiles

News
Technology
View Tech Report

IT Spend

$99.6KThis year, PlumeSTARS is projected to spend $99.6K on IT, according to Aberdeen.

Active Website Tech Count

36PlumeSTARS is actively using 36 technologies for its website, according to BuiltWith. These include IPhone / Mobile Compatible, Viewport Meta, and  SSL by Default.

Total IP

3The intellectual property of PlumeSTARS includes 3 registered patents primarily in the 'Medical Or Veterinary Science; Hygiene' category, according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is PlumeSTARS's headquarters? PlumeSTARS is located in Parma, Emilia-Romagna, Italy.Who invested in PlumeSTARS? PlumeSTARS is funded by EISMEA.When was the last funding round for PlumeSTARS? PlumeSTARS closed its last funding round on
obfuscation
from a Grant round.Who are PlumeSTARS's competitors? Alternatives and possible competitors to PlumeSTARS may include Teva Pharmaceuticals, MannKind, and  Chiesi Farmaceutici.How much funding has PlumeSTARS raised to date? PlumeSTARS has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(f8e1fc8 1)
|